[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. 877 Introduced in Senate (IS)]







110th CONGRESS
  1st Session
                                 S. 877

 To amend the Controlled Substances Act to add human growth hormone to 
  schedule III, to prohibit the sale of prescriptions for controlled 
     substances for illegitimate purposes, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 14, 2007

  Mr. Schumer introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
 To amend the Controlled Substances Act to add human growth hormone to 
  schedule III, to prohibit the sale of prescriptions for controlled 
     substances for illegitimate purposes, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Controlling the Abuse of 
Prescriptions Act of 2007''.

SEC. 2. HUMAN GROWTH HORMONE.

    (a) In General.--Schedule III of section 202(c) of the Controlled 
Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the 
following:
    ``(f) Growth hormone, recombinant human growth hormone, or human 
growth hormone.''.
    (b) Effective Date.--The amendment made by this section shall take 
effect 30 days after the date of enactment of this Act.

SEC. 3. BAD FAITH SALE OF PRESCRIPTIONS.

    (a) In General.--Part D of the Controlled Substances Act (21 U.S.C. 
841 et seq.) is amended by adding at the end the following:

``SEC. 424. BAD FAITH SALE OF PRESCRIPTIONS.

    ``(a) Offense.--It shall be unlawful for any practitioner to 
knowingly sell, or otherwise transfer or deliver in exchange for 
anything of pecuniary value, a prescription for a controlled substance, 
other than in good faith in the course of the professional practice of 
that practitioner.
    ``(b) Penalty.--Any practitioner that violates subsection (a) shall 
be fined under title 18, United States Code, imprisoned not more than 5 
years, or both.''.
    (b) Technical and Conforming Amendment.--The table of contents for 
the Controlled Substances Act (21 U.S.C. 801 et seq.) is amended by 
inserting after the item relating to section 423 the following:

``Sec. 424. Bad faith sale of prescriptions.''.
                                 <all>